In Brief: Sandoz' Tavist 1/Tavist-D
This article was originally published in The Tan Sheet
Executive Summary
Sandoz' Tavist 1/Tavist-D: Receive Oct. 31 FDA approval of common cold indication for antihistamine and antihistamine/decongestant. FDA's Nonprescription and Pulmonary-Allergy Drugs Advisory Committees recommended approval for the cold indication based on company data nearly a year ago ("The Tan Sheet" Nov. 20, 1995, p. 5)...